3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
NET
42
Gastrointestinal
42
Endocrine
42
Sarcoma
4
CNS
4
Thoracic
3
Other solid neoplasm
2
Lymphoid
2
Head & Neck
2
Gynecologic
2
Genitourinary
1
Breast
1
Conditions
Lymphoma
2570
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2086
Lymphoma, Non-Hodgkin
2057
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Lymphoma, Follicular
1651
Lymphoma, Large B-Cell, Diffuse
1597
Leukemia
1172
Hodgkin Disease
1128
Lymphoma, Mantle-Cell
1110
Burkitt Lymphoma
887
Leukemia, Myeloid, Acute
885
Lymphoma, B-Cell, Marginal Zone
788
Recurrence
779
Multiple Myeloma
744
Lymphoma, B-Cell
704
Myelodysplastic Syndromes
615
Neoplasms
494
Lymphoma, T-Cell, Cutaneous
479
Waldenstrom Macroglobulinemia
470
Lymphoma, Large-Cell, Immunoblastic
456
Mycosis Fungoides
383
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
382
Lymphoma, Large-Cell, Anaplastic
362
Sezary Syndrome
321
Lymphoma, T-Cell, Peripheral
321
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
307
Hematologic Neoplasms
299
Myeloproliferative Disorders
288
Neoplasms, Plasma Cell
270
Blast Crisis
261
Interventions
pasireotide
1
amino-acid, glucose, and electrolyte solution
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Gastro-enteropancreatic neuroendocrine tumor
×
Lymphoid
×
Clear all
NCT06441331
2026-05-01
KinLET
ITM Solucin GmbH
Phase 1
Recruiting
20 enrolled
NCT06784752
2026-04-30
NETTER-3
Novartis
Phase 3
Recruiting
240 enrolled